I've finally found a health MOT that works: The Mail's DR MAX PEMBERTON has always dismissed full-body scans... but now reveals the one everyone should get

I'll be honest - I wasn't particularly keen on the idea. A full-body health scan? At my age? I'm 46, eat properly, I don't ...
The American Journal of Managed Care

Rilzabrutinib Offers a New, Well-Tolerated Option for Patients With ITP: David Kuter, MD, DPhil

Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.